Skip to Content

MenQuadfi Dosage

Medically reviewed by Drugs.com. Last updated on April 23, 2020.

Generic name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL
Dosage form: solution for intramuscular injection

Preparation for Administration

MenQuadfi is a clear solution.

Parenteral drug products should be inspected visually for particulate matter and/or discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered. Discard the vial with any unused portion.

Dose and Schedule

Administer MenQuadfi as a single 0.5 mL injection intramuscularly.

Primary Vaccination

  • Individuals 2 years of age and older receive a single dose.

Booster Vaccination

  • A single dose of MenQuadfi may be administered to individuals 15 years of age and older who are at continued risk for meningococcal disease if at least 4 years have elapsed since a prior dose of meningococcal (Groups A, C, W, Y) conjugate vaccine.

More about MenQuadfi (meningococcal conjugate vaccine)

Consumer resources

Other brands
Menactra, Menveo

Professional resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.